Primitive Neuroectodermal Tumor — Trials

Primitive Neuroectodermal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

673 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 146
Recruiting: 80
Ph III recruiting: 8
Growth YoY: −33.3%
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 601–650 of 673 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00004188	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma	completed	Phase 3	495	Children's Oncology GroupNETWORK	2	May 17, 2013	clinicaltrials
NCT00003425	Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect	completed	Phase 1 / Phase 2	25	University of KentuckyOTHER	1	Apr 26, 2013	clinicaltrials